125 related articles for article (PubMed ID: 3583325)
1. Liposomes as adjuvants with immunopurified tetanus toxoid: the immune response.
Davis D; Davies A; Gregoriadis G
Immunol Lett; 1987 Apr; 14(4):341-8. PubMed ID: 3583325
[TBL] [Abstract][Full Text] [Related]
2. Liposomes as adjuvants with immunopurified tetanus toxoid: influence of liposomal characteristics.
Davis D; Gregoriadis G
Immunology; 1987 Jun; 61(2):229-34. PubMed ID: 3596639
[TBL] [Abstract][Full Text] [Related]
3. Primary immune response to liposomal tetanus toxoid in mice: the effect of mediators.
Davis D; Gregoriadis G
Immunology; 1989 Oct; 68(2):277-82. PubMed ID: 2509329
[TBL] [Abstract][Full Text] [Related]
4. Liposomes as immunological adjuvants: antigen incorporation studies.
Gregoriadis G; Davis D; Davies A
Vaccine; 1987 Jun; 5(2):145-51. PubMed ID: 3604394
[TBL] [Abstract][Full Text] [Related]
5. The immunological co-adjuvant action of liposomal interleukin-2: the role of mode of localisation of the cytokine and antigen in the vesicles.
Gursel M; Gregoriadis G
J Drug Target; 1998; 5(2):93-8. PubMed ID: 9588865
[TBL] [Abstract][Full Text] [Related]
6. A novel positively-charged lipid 1,2-bis(hexadecylcycloxy)-3-trimethyl aminopropane (BisHOP) enhances the adjuvant effect of liposomes on encapsulated tetanus toxoid.
Tan L; Gregoriadis G
Asian Pac J Allergy Immunol; 1991 Jun; 9(1):21-4. PubMed ID: 1776976
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-15 acts as an immunological co-adjuvant for liposomal antigen in vivo.
Gursel M; Gregoriadis G
Immunol Lett; 1997 Mar; 55(3):161-5. PubMed ID: 9161882
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant properties of non-phospholipid liposomes (Novasomes) in experimental animals for human vaccine antigens.
Gupta RK; Varanelli CL; Griffin P; Wallach DF; Siber GR
Vaccine; 1996 Feb; 14(3):219-25. PubMed ID: 8920703
[TBL] [Abstract][Full Text] [Related]
9. Mannose-mediated targeted immunoadjuvant action of liposomes.
Garcon N; Gregoriadis G; Taylor M; Summerfield J
Immunology; 1988 Aug; 64(4):743-5. PubMed ID: 3169846
[TBL] [Abstract][Full Text] [Related]
10. Immunoadjuvant action of liposomes: comparison with other adjuvants.
Gregoriadis G; Panagiotidi C
Immunol Lett; 1989 Feb; 20(3):237-40. PubMed ID: 2714847
[TBL] [Abstract][Full Text] [Related]
11. Liposomes enhance the immunogenicity of reconstituted influenza virus A/PR/8 envelopes and the formation of protective antibody by influenza virus A/Sichuan/87 (H3N2) surface antigen.
Gregoriadis G; Tan L; Ben-Ahmeida ET; Jennings R
Vaccine; 1992; 10(11):747-53. PubMed ID: 1441730
[TBL] [Abstract][Full Text] [Related]
12. Pertussis toxin enhanced IgG1 and IgE responses to primary tetanus immunization are mediated by interleukin-4 and persist during secondary responses to tetanus alone.
Samore MH; Siber GR
Vaccine; 1996 Mar; 14(4):290-7. PubMed ID: 8744555
[TBL] [Abstract][Full Text] [Related]
13. Oral vaccine models: multiple delivery systems employing tetanus toxoid.
Jackson RJ; Staats HF; Xu-Amano J; Takahashi I; Kiyono H; Hudson ME; Gilley RM; Chatfield SN; McGhee JR
Ann N Y Acad Sci; 1994 Aug; 730():217-34. PubMed ID: 8080173
[TBL] [Abstract][Full Text] [Related]
14. Tetanus toxoid-loaded transfersomes for topical immunization.
Gupta PN; Mishra V; Singh P; Rawat A; Dubey P; Mahor S; Vyas SP
J Pharm Pharmacol; 2005 Mar; 57(3):295-301. PubMed ID: 15807984
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and lower dose requirement of polymer entrapped tetanus toxoid co-administered with alum.
Katare YK; Panda AK
Vaccine; 2006 Apr; 24(17):3599-608. PubMed ID: 16513224
[TBL] [Abstract][Full Text] [Related]
16. Liposome adjuvanticity: influence of dose and protein:lipid ratio on the humoral response to encapsulated and surface-linked antigen.
Thérien HM; Shahum E; Fortin A
Cell Immunol; 1991 Sep; 136(2):402-13. PubMed ID: 1873824
[TBL] [Abstract][Full Text] [Related]
17. Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles.
Katare YK; Muthukumaran T; Panda AK
Int J Pharm; 2005 Sep; 301(1-2):149-60. PubMed ID: 16023313
[TBL] [Abstract][Full Text] [Related]
18. Development of novel fusogenic vesosomes for transcutaneous immunization.
Mishra V; Mahor S; Rawat A; Dubey P; Gupta PN; Singh P; Vyas SP
Vaccine; 2006 Jul; 24(27-28):5559-70. PubMed ID: 16730102
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of diphtheria toxoid and poly(I:C) loaded cationic liposomes after hollow microneedle-mediated intradermal injection in mice.
Du G; Leone M; Romeijn S; Kersten G; Jiskoot W; Bouwstra JA
Int J Pharm; 2018 Aug; 547(1-2):250-257. PubMed ID: 29870743
[TBL] [Abstract][Full Text] [Related]
20. Immunoadjuvant activity of a liposomal IL-6 formulation.
Duits AJ; van Puijenbroek A; Vermeulen H; Hofhuis FM; van de Winkel JG; Capel PJ
Vaccine; 1993; 11(7):777-81. PubMed ID: 8342326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
